HIVEs 220M Canada AI Deal|Stock Stalls Below 4 as Revenue Is 12 Months Away

Canada's Largest AI Deal — and a Stock That Won't Move

HIVE Digital Technologies signed a $220 million GPU cloud contract with Bell Canada and Cohere on June 18, the largest AI infrastructure deal announced in Canada to date. The stock surged 12% in premarket trading, then stalled — hovering near $3.97, well below the CA$8.45 fair value that analysts cite as its reset price. The bottleneck is time: the $70 million in annual recurring revenue this deal adds does not begin flowing until late 2026 or early 2027. Today's investors are being asked to hold a stock with Strong Sell technical signals in exchange for revenue that arrives six to twelve months from now. HIVE's subsidiary BUZZ High Performance Computing secured 2,304 NVIDIA Grace Blackwell GPUs — some of the most powerful AI training chips in production — to be deployed at Bell's purpose-built facility in Merritt, British Columbia. The infrastructure will power Cohere's enterprise AI models, which already serve Canadian federal agencies. Ottawa has committed over $2 billion to Canada's sovereign AI compute strategy and directed $240 million directly to Cohere; this deal is the physical compute layer that makes those commitments real. HIVE's contracted high-performance computing revenue has now crossed $100 million — a threshold that would have seemed improbable eighteen months ago for a company that made its name mining Bitcoin. But contracts and revenue recognition are not the same thing, and the market has learned to price that gap.

The $70 Million That Doesn't Exist Yet

HIVE's realized annual recurring revenue from HPC today stands at $35 million. The Bell-Cohere deal adds a contracted $70 million — more than doubling the current base — but that figure does not hit the income statement until the Merritt facility goes live. That go-live is targeted between Q4 2026 and Q1 2027, a six-to-twelve month window with no hard deadline. In the interval, HIVE is funding the NVIDIA Grace Blackwell hardware purchase through its $115 million convertible note offering, a zero-percent exchangeable note due 2031 completed in April. The financing terms are favourable — 0% interest, institutional demand strong enough to upsize from $75 million — but exchangeable notes carry conversion pressure: if HIVE's share price moves, the dilution math shifts. This is the structural tension the deal has not resolved. HIVE's Q3 FY2026 revenue reached $93.1 million, up 219% year over year, with gross margin expanding more than sixfold to $32.1 million. But the GAAP net loss in the same quarter was $91.3 million, driven by accelerated depreciation on new ASIC fleets and non-cash revaluations. HC Wainwright rates the stock Buy with a C$6.00 price target, calling near-term growth prospects underappreciated. TipRanks' Spark model rates it Neutral with a Strong Sell technical signal, noting the price is below all key moving averages with negative momentum indicators. Both assessments are grounded in the same disclosed facts; what separates them is entirely a question of how much weight to give revenue that has been contracted but not yet recognized. The consensus narrative on Simply Wall St — followed by 64.3% of tracked investors — puts fair value at CA$8.45 against a last close near CA$3.02. That gap is wide enough to be compelling and wide enough to be a trap.

What the Strong Sell Signal Is Actually Telling You

A Strong Sell technical reading on a stock that just announced Canada's largest AI deal is not a contradiction — it is a timing statement. The stock gained 125% over the prior twelve months before this announcement. That move preceded the Bell-Cohere contract; the market was already pricing a pivot narrative through late 2025 and early 2026. What the technicals now reflect is a stock that has moved substantially on announcement risk — May's 28% single-day surge on 111 million shares, eight times average daily volume, was the largest single-day repricing event — and now must wait for the underlying business to deliver. The buried assumption in the bull case is that the re-rating from Bitcoin miner to AI infrastructure provider is permanent and that no execution slip on the Merritt go-live will be tolerated. HIVE's five-year total return is negative 86.75%. The company's transformation is real and the revenue growth is real, but so is the history of misaligned timelines in its sector. Keel Infrastructure — formerly Bitfarms — sold its last Paraguay mining facility in April and is running the same AI pivot playbook; the market has seen this movie before. The convertible note adds a second layer of complexity: $115 million in 0% exchangeable senior notes due 2031 means HIVE raised capital at no interest cost, which is exceptional, but the exchange feature means if the stock appreciates sharply, dilution follows. Institutional buyers who participated in the upsized note offering are not the same capital as equity holders watching the stock stall below $4. One class holds a fixed-income instrument with equity upside; the other holds equity with no income protection during the wait. That asymmetry is not priced into the 12% premarket move.

What Decides the Re-Rating

The single variable that resolves this setup is the Merritt facility go-live date and first revenue recognition from the NVIDIA GB200 deployment. HIVE's CEO Aydin Kilic stated contracted HPC revenue has surpassed $100 million and the Blackwell deployment will add approximately $70 million in annual recurring revenue on top of the existing $35 million realized ARR. When that $70 million moves from contracted to recognized, the income statement changes structurally — not by analyst upgrade but by reported cash flow. The verification question is whether the deployment stays on the late 2026 to early 2027 schedule, or whether supply chain constraints, commissioning delays, or power provisioning at the Merritt site introduce slippage. Bell's Q4 2025 partnership announcement referenced 6.5 MW of immediate capacity at Merritt with an option for additional power over time; the Blackwell deployment will consume substantially more. The counter-evidence in the pool is real: HIVE's five-year return of negative 86.75% and its ongoing GAAP losses mean the bull case rests entirely on a timeline the company has not yet proven it can execute. If the Merritt go-live slips beyond Q1 2027, the $115 million convertible notes reach a period where refinancing pressure begins to build, and the stock's technical weakness will have been correct. For a holder, the monitoring variable is the Merritt commissioning update — not the next analyst price target revision. For a watcher, entry makes sense only after a confirmed go-live date is published, not on the contract announcement alone. The deal is real; the revenue is not — and that gap is what the market is pricing with a stall at $3.97.